Hytro, the blood flow restriction (BFR) wearable designed to improve sports performance, has added James Moore as the company’s new Head of Medical.
This news follows previous announcements from Hytro welcoming board advisors Peter McKnight, Coaching and Sport Science Director at Hintsa Performance, along with Yanto Barker, founder and Managing Director of Le Col, and Nikki Doucet, former Nike Senior Exec.
As a globally-recognised consultant physiotherapist, Moore is co-founder and Director of Sports and Exercise Medicine at CHHP London. According to Hytro he… ‘will bring unparalleled experience, gained from working directly with world leading athletes as well as his previous role as Team GB’s Deputy Chef de Mission, to further develop Hytro as the leaders in Blood Flow Restriction (BFR) wearables.’
Moore has a reputation for being at the cutting edge of healthcare for performance. Having lectured widely on the subject, he will add his knowledge of BFR to the Hytro team and seeks to broaden the reach and education surrounding this method.
More specifically, Moore will be working with Hytro to education on BFR’s benefits to elite level coaches, practitioners and physios, while providing strategic and practical advice on product development and market penetration.
James Moore, Head of Medical at Hytro said “I have talked about the benefits of BFR with my clients for years – but nobody was bringing this unrivalled method of training to elites and amateurs in an efficient, safe and accessible way.
“Working with the guys at Hytro, it’s clear that their products will be taking BFR on a shift from expensive kit in elite performance physio rooms and scientific journals to the masses, with one easy product. This brand is revolutionising the recovery and performance market, so I‘m excited to bring the benefits of Hytro to more coaches to help their athletes win.”
Dr Warren Bradley, Founder and Head of Elite Performance at Hytro, added “Like the rest of the industry, I have known and respected James’ work for a long time, seeing him develop athletes into world champions.
“We’re delighted to see his enthusiasm for Hytro and we can’t wait to work together to continue this exciting journey to bring the recovery and performance benefits of BFR to a wider audience.”
